Clinical effectiveness and safety of transcranial direct current electrical stimulation on major depressive disorder

Omori M Ichiro0 sites10 target enrollmentSeptember 12, 2022

Overview

No summary available.

Registry

who.int

Start Date

September 12, 2022

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

Omori M Ichiro

•The inclusion criteria are as follows:
•1\) Inpatients in the department of psychiatry of the University of Fukui Hospital
•2\) Male or female patients between 25 and 90 years of age
•3\) Diagnosed major depressive disorder according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM\-5; American Psychiatric Association)
•4\) Moderate to severe depressive state according to the Hamilton Depression Rating Scale (score \<\= 17\)
•5\) Patients provides written informed consent prior to initiation of any study procedures

•Exclusion criteria
•1\) Past or current diagnosis of schizophrenia, schizoaffective disorder, bipolar I disorder and bipolar II disorder
•2\) Presence of severe physical diseases or in the terminal phase of the disease
•3\) Under treatment for thyroid function abnormality
•4\) With abnormal EEG findings
•5\) With intracranial space\-occupying lesion
•6\) pregnancy
•7\) Need to be cured urgently due to severe depressive state with inability take any food and/or severe suicidal ideation
•8\) Lack of cooperation regarding 20\-minutes procedure of tDCS due to severe agitation